[go: up one dir, main page]

AR097111A1 - Combinación y método para la administración a un animal - Google Patents

Combinación y método para la administración a un animal

Info

Publication number
AR097111A1
AR097111A1 ARP140102826A ARP140102826A AR097111A1 AR 097111 A1 AR097111 A1 AR 097111A1 AR P140102826 A ARP140102826 A AR P140102826A AR P140102826 A ARP140102826 A AR P140102826A AR 097111 A1 AR097111 A1 AR 097111A1
Authority
AR
Argentina
Prior art keywords
combination
animal
administration
material containing
plant material
Prior art date
Application number
ARP140102826A
Other languages
English (en)
Original Assignee
Omnigen Res L L C
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Omnigen Res L L C filed Critical Omnigen Res L L C
Publication of AR097111A1 publication Critical patent/AR097111A1/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/87Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716Glucans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/06Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/82Theaceae (Tea family), e.g. camellia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Mycology (AREA)
  • Rheumatology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Inorganic Chemistry (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Se revelan las formas de realización de una combinación y método para la administración a un animal. El animal puede tener -o estar en riesgo de contraer- un trastorno inflamatorio. La combinación incluye: (a) material vegetal que contiene polifenoles, un extracto vegetal derivado del material vegetal que contiene polifenoles o una mezcla de ellos; y (b) glucano, sílice, arcilla mineral, mananos o cualquier combinación de ellos.
ARP140102826A 2013-07-29 2014-07-29 Combinación y método para la administración a un animal AR097111A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201361859689P 2013-07-29 2013-07-29

Publications (1)

Publication Number Publication Date
AR097111A1 true AR097111A1 (es) 2016-02-17

Family

ID=51355650

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP140102826A AR097111A1 (es) 2013-07-29 2014-07-29 Combinación y método para la administración a un animal

Country Status (3)

Country Link
AR (1) AR097111A1 (es)
TW (1) TW201601730A (es)
WO (1) WO2015017336A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN120531733A (zh) * 2016-06-01 2025-08-26 礼蓝动物保健有限公司 用于治疗和预防动物的过敏性和/或炎症性疾病的取代吲唑
PT3573472T (pt) * 2017-01-24 2025-01-22 Omnigen Res L L C Suplemento alimentar granulado e métodos para produção e utilização
CN114177187B (zh) * 2021-12-10 2024-10-22 西北大学 富含α2,6-唾液酸修饰的羊乳酸性游离寡糖在制备免疫调节药物或功能食品中的应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10143146B4 (de) * 2001-09-03 2009-06-10 Boers, Johannes, Dr. med. vet. Antiarthrotische Zubereitung und deren Verwendung
WO2007011674A2 (en) * 2005-07-15 2007-01-25 Baker Donald J Compositions and methods for treating and preventing inflammatory and/or degenerative processes in humans and other animals
WO2010097643A1 (en) * 2009-02-24 2010-09-02 Novatech Istrazivanje D.O.O. Formulation based on micronized zeolite, green tea extract, and genistein as a therapeutic agent for reduction of body weight and cellulite
HUE052368T2 (hu) * 2012-10-02 2021-04-28 Oil Dri Corp Of America Agyag termék és annak alkalmazásai

Also Published As

Publication number Publication date
WO2015017336A1 (en) 2015-02-05
TW201601730A (zh) 2016-01-16

Similar Documents

Publication Publication Date Title
NI201600071A (es) Compuestos de inhibidor de autotaxina
CL2016000153A1 (es) Derivados de pirrolamida sustituidos con glioxamida y su uso como medicamentos para el tratamiento de la hepatitis b
CL2016000017A1 (es) Carboxamidas de anillo de 4 miembros empleadas como nematicidas
UY35500A (es) Indazoles sustituidos con heteroarilo
MX386298B (es) Composicion farmaceutica que comprende adalimumab.
CL2017000394A1 (es) Composición que contiene cineol para la administración nasal
CL2016000009A1 (es) Tratamiento de rosacea papulopustular con ivermectina.
CL2015001772A1 (es) Composición farmacéutica para el tratamiento de dolor cabeza, y método de preparación de la misma.
CL2016003074A1 (es) Compuestos derivados de 2-oxi-2-fenil-n-5-pirrolidin-3-ilamino-1,3,4-tiadiazol-2-ilacetamida, inhibidores gls1 composición farmacéutica y su uso para tratar el cáncer.
CL2015003713A1 (es) Composición herbicida que tiene mejorada seguridad en plantas
CR20170005A (es) Derivados de insoindolina
NI201600070A (es) Inhibidores tetracíclicos de autotaxina
CL2016001210A1 (es) Análogos de bicalutamida o (s)- bicalutamida como compuestos activadores de la exocitosis para su uso en el tratamiento de un desorden de acúmulo lisosomal o glucogenosis.
SV2017005466A (es) Pirazolpiridinaminas como inhibidores de mknk1 y mknk2
CL2016000038A1 (es) Piraxolo-piridinaminas sustituidas
DOP2015000298A (es) Compuestos nuevos para el tratamiento del cáncer
CL2017000587A1 (es) Derivados de tetrahidroquinolina como inhibidores de bromodominio
CL2014001862A1 (es) Compuestos derivados de morofolinilo sustituido, útiles como inhibidores de mogat-2; composicion farmaceutica que los comprende; uso en el tratamiento de hipertrigliceridemia.
UY36217A (es) Compuestos piridona sustituídos, composiciones farmacéuticas y métodos de uso.
CL2015003433A1 (es) Derivados de tilosina y método para su preparación
AR097111A1 (es) Combinación y método para la administración a un animal
CL2015003460A1 (es) Composiciones oftálmicas acuosas tópicas que contienen un derivado de 1h-indol-1-carboxamida y uso de estas para el tratamiento de una enfermedad oftálmica
CL2015001502A1 (es) Composición farmacéutica que comprende desloratadina y prendnisolona y uso de la misma.
CU20170134A7 (es) 2-tiopirimidinonas
CL2016002653A1 (es) Combinación farmacéutica que comprende brexpiprazol y nalmefeno; composición farmacéutica que los comprende; kit farmacéutico; y uso de la combinación para la prevención y tratamiento de un trastorno relacionado con sustancias como el alcohol.

Legal Events

Date Code Title Description
FB Suspension of granting procedure